Pre-market hot trades in US stocks: NewGenIvf pre-market down 17.88%; Beneficient pre-market down 17.11%

Popular Pre-Market Trades in US Stocks NewGenIvf, down 17.88% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Beneficient, down 17.11% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Top Gainers in Pre-Market US Stocks A SPAC III Acquisition, up 215.17% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. Enveric Biosciences, up 77.53% in pre-market. Based on recent news, On December 9, Enveric Biosciences released new research findings showing significant progress in the field of mental health treatment. This news triggered a strong market reaction, driving the stock price up significantly. On December 8, the company announced a partnership agreement with a leading pharmaceutical company to jointly develop new drugs. This collaboration is seen by the market as a positive signal for the company's future growth, further boosting investor confidence. On December 7, analysts upgraded their rating for Enveric Biosciences, believing it has great potential in emerging markets. This rating adjustment attracted more investor attention, driving the stock price up. The mental health treatment sector has performed strongly recently, with high investor interest. Biodexa Pharmaceuticals, up 72.24% in pre-market, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation